Correlation of high p95HER2:HER2 ratio with poor outcome in two phase II clinical trials of trastuzumab-treated HER2-positive metastatic breast cancer.
   Google Scholar   
Citation:
J Clin Oncol vol 34 (suppl) abstr 603
Meeting Instance:
ASCO 2016
Year:
2016
Type:
Abstract
Sub type:
Poster Discussion
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Parents:
None
Children:
2728  
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
 
Grants:
 
Corr. Author:
 
Authors:
                               
Networks:
 
Study
Multiple Studies, or Legacy Studies in Alliance Study:
NCCTG-N0337, NCCTG-N98-32-52
Phases:
2
Keywords: